m6A modification suppresses innate anti-tumour immunity in colorectal cancer by limiting alu-derived dsRNA accumulation
6d ago· 1 min readNews
Source
METTL3-mediated m6A modification in CRC limits Alu-derived dsRNA, suppressing innate anti-tumor immunity. Understanding this can revolutionize cancer immunotherapy. PMID:42135281, Nat Commun 2026, @NatureComms #Medsky #Pharmsky #RNA #ASHG #ESHG 🧪
You might also wanna read

DDX6 helicase suppresses innate immune responses by disrupting endogenous double-stranded RNA stability in cancer cells
This research article reveals that DEAD-box RNA helicase 6 (DDX6) interacts with ADAR1 to repress editing of A:C mismatches in double-strand

Cdh1 stabilizes STING to boost innate immune activation in renal cell carcinoma, study finds
This article presents research by Zhu et al. on the role of the APC/C adaptor protein Cdh1 in stabilizing STING (a key innate immune sensor)
Programming the immunological properties of mRNA vaccines for cancer
nature.com·5d ago

New CRISPR Technique Selectively Destroys Cancer Cells with Common Mutation
Researchers at UC Berkeley, UCSF, and Gladstone Institutes have developed a novel CRISPR-based technique called "RNA-Triggered Chromatin Shr
innovativegenomics.org·12d agoEfficient mRNA delivery to resting T cells to reverse HIV latency
nature.com·1y ago

Pan-cancer AI atlas reveals diversity and spatial organization of tertiary lymphoid structures in tumors
Researchers built a pan-cancer atlas of tertiary lymphoid structures (TLSs) in human tumors, developing an AI-based framework to detect and
Comments
Sign in to join the conversation.
No comments yet. Be the first.
